{"title":"甲状旁腺激素对骨质疏松症的影响简要介绍一下当前的知识","authors":"M. Zahmatkesh","doi":"10.34172/jpd.2023.11215","DOIUrl":null,"url":null,"abstract":"Osteoporosis is a disease characterized by losing bone tissue, resulting in increased bone fragility and an increased risk of fractures. Parathyroid hormone (PTH) plays an essential role in the development of osteoporosis. High levels of PTH for prolonged periods lead to a decrease in bone density. However, intermittent administration of PTH is an effective treatment for osteoporosis, suggesting that careful dosing of PTH can have a therapeutic benefit in the treatment of osteoporosis.","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of parathyroid hormone on osteoporosis; a short look at the current knowledge\",\"authors\":\"M. Zahmatkesh\",\"doi\":\"10.34172/jpd.2023.11215\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Osteoporosis is a disease characterized by losing bone tissue, resulting in increased bone fragility and an increased risk of fractures. Parathyroid hormone (PTH) plays an essential role in the development of osteoporosis. High levels of PTH for prolonged periods lead to a decrease in bone density. However, intermittent administration of PTH is an effective treatment for osteoporosis, suggesting that careful dosing of PTH can have a therapeutic benefit in the treatment of osteoporosis.\",\"PeriodicalId\":16657,\"journal\":{\"name\":\"Journal of Parathyroid Disease\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Parathyroid Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/jpd.2023.11215\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Parathyroid Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jpd.2023.11215","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impact of parathyroid hormone on osteoporosis; a short look at the current knowledge
Osteoporosis is a disease characterized by losing bone tissue, resulting in increased bone fragility and an increased risk of fractures. Parathyroid hormone (PTH) plays an essential role in the development of osteoporosis. High levels of PTH for prolonged periods lead to a decrease in bone density. However, intermittent administration of PTH is an effective treatment for osteoporosis, suggesting that careful dosing of PTH can have a therapeutic benefit in the treatment of osteoporosis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
